In this issue:
Siponimod vs placebo in SPMS
Comparative effectiveness of rituximab and DMTs for MS
Relapse occurrence during pregnancy in the new MS treatment era
A standardised frankincense extract reduces disease activity in RRMS
Long-term impact of early MS treatment on risk of disability pension
Progressive MS patients show substantial lesion activity that correlates with clinical disease severity
Value of OCBs in the MS diagnostic criteria
Exosomal content of MOG correlated with MS disease activity
CSF mtDNA is elevated in MS and responds to treatment
Asymptomatic SC lesions do not predict the time to disability in early MS
Please login below to download this issue (PDF)